Leveraging HyperLight's proprietary TFLN Chipletâ„¢ platform, this revolutionary modulator achieves an unprecedented half-wave ...
HyperLight, creator of the TFLN Chipletâ„¢ platform, today announced the launch of its groundbreaking 110 GHz Low Vp Intensity ...
GlobalData on MSN19h
Surrozen drops hepatitis drug after Phase I flopSurrozen said despite SZN-043 demonstrating changes in liver function assays, there was not enough clinical benefit for ...
Moreover, only one antenna works at a time, thus the instantaneous power is very small. In this paper, a new waveform based on phase modulation (PM) is proposed to realize multi-beamforming, which ...
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...
MusicRadar on MSN19h
Synclavier Digital returns with another new synth based on the '80s classic - except this time, it looks a little more familiarThe ORK II appears to be a new instrument that packs the Regen's architecture into a retro-styled keyboard reminiscent of the ...
Abstract: This paper proposes a method for generating quadrature self-mixing interference (SMI) signals using current modulation for real-time displacement sensing. By applying a square-wave current ...
Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219 SYX-5219 is a ...
Hamamatsu's low-noise LCOS-SLMs significantly reduce phase fluctuations, enhancing accuracy in quantum computing and ...
People who have had COVID-19, even mild cases, tend to have cardiovascular imbalances in the short and medium term and need ...
First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback